DUX4L13: A Drug Target / Disease Biomarker (G100289581)

Target Name: DUX4L13

NCBI ID: G100289581

DUX4L13

Other Name(s): Double homeobox 4 like 13 (pseudogene) | double homeobox 4 like 13 (pseudogene)

DUX4L13: A Drug Target / Disease Biomarker

DUX4L13 is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the superfamily of core leucine-rich repeat (CLR) proteins, which are characterized by the presence of a repeated sequence of leucine amino acids in their N-terminus.

DUX4L13 is of particular interest as a potential drug target or biomarker because of its role in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of DUX4L13 is its role in the regulation of inflammation. It has been shown to play a key role in the development and progression of several types of cancer, including breast, ovarian, and prostate cancer.

DUX4L13 has also been shown to be involved in the regulation of pain and inflammation in the nervous system. It has been shown to play a role in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and has also been linked to the development of autoimmune disorders.

DUX4L13 is also of interest as a potential biomarker for several types of cancer, including pancreatic, breast, and ovarian cancer. It has been shown to be a reliable and sensitive marker for these cancers, with potential utility in clinical trials.

In addition to its potential as a drug target or biomarker, DUX4L13 is also of interest as a potential therapeutic approach. Studies have shown that DUX4L13 can be targeted with small molecules, antibodies, and other therapeutic agents, providing a promising avenue for the development of new treatments for a variety of diseases.

Overall, DUX4L13 is a protein that has significant potential as a drug target or biomarker, and further research is needed to fully understand its role in the development and progression of various diseases.

Protein Name: Double Homeobox 4 Like 13 (pseudogene)

The "DUX4L13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUX4L13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets